Podcast Episodes

Back to Search
PayPal's Stock: Buy or Bust?
PayPal's Stock: Buy or Bust?

PayPals stock plummets, raising concerns among investors due to slowing revenue growth and stagnant earnings per share. Despite appearing cheap,…

2 days, 22 hours ago

Short Long
View Episode
Nuclear Power Stocks: GE Vernova & TC Energy
Nuclear Power Stocks: GE Vernova & TC Energy

Nuclear Energy Stocks: GE Vernova and TC Energy Lead the Pack

GE Vernova, a multifaceted energy company, is making waves in the nuclear en…

2 days, 22 hours ago

Short Long
View Episode
Amneal Pharmaceuticals: Is It Worth the Risk?
Amneal Pharmaceuticals: Is It Worth the Risk?

Amneal Pharmaceuticals stock is currently at $12.64, mirroring the broader markets performance. Over the past six months, its gained 6.2%, laggi…

2 days, 22 hours ago

Short Long
View Episode
Patel Appeals Defamation Case Against Figliuzzi
Patel Appeals Defamation Case Against Figliuzzi

FBI Director Kash Patel appeals defamation case against ex-official Frank Figliuzzi, who accused Patel of frequenting nightclubs over FBI headqu…

2 days, 23 hours ago

Short Long
View Episode
Cellebrite's AI-Driven Growth: Q1 2026 Earnings
Cellebrite's AI-Driven Growth: Q1 2026 Earnings

Cellebrites Q1 2026 earnings exceeded expectations, with a 21% YoY increase in ARR to $493M and a 29% YoY rise in adjusted EBITDA to $30.6M. The…

2 days, 23 hours ago

Short Long
View Episode
Mixed Q1 Results for Professional Tools Stock
Mixed Q1 Results for Professional Tools Stock

Professional tools and equipment stocks had a mixed Q1, with nine out of nine topping revenue estimates but falling short on Q2 guidance, leadin…

2 days, 23 hours ago

Short Long
View Episode
Defense Contractors Q1 Beats, Despite Stock Drops
Defense Contractors Q1 Beats, Despite Stock Drops

Defense contractors had a mixed first quarter, with thirteen key stocks beating revenue estimates by 3.4% overall. Northrop Grumman led with a 4…

2 days, 23 hours ago

Short Long
View Episode
Siren Fund's $76M Veradermics Bet
Siren Fund's $76M Veradermics Bet

Siren Hedge Fund Bets Big on Veradermics: A Biotech Poised to Revolutionize Hair Loss Treatments

Siren Hedge Fund recently acquired a sign…

2 days, 23 hours ago

Short Long
View Episode
Siren's $30M Erasca Bet Signals RAS Cancer Hope
Siren's $30M Erasca Bet Signals RAS Cancer Hope

New York hedge fund Siren has invested heavily in Erasca, a biotech company targeting tough cancers. Siren bought 2.5 million shares, valued at …

2 days, 23 hours ago

Short Long
View Episode
Biogen & Novo Nordisk: Top Healthcare Stocks for 2026
Biogen & Novo Nordisk: Top Healthcare Stocks for 2026

Biogen and Novo Nordisk emerge as top healthcare stocks for 2026, focusing on neurology and diabetes treatments respectively. Biogens Leqembi sa…

2 days, 23 hours ago

Short Long
View Episode

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us